North American Biologicals Inc. expects to report fourth-quarter earnings of about $1.4 million, or about 10 cents a share, said David J. Gury, president, chairman and chief executive.
The Miami supplier of blood plasma had a net loss of $514,000, or four cents a share, a year earlier.
North American Biologicals shares soared 19% on the news, up 81.25 cents to $5.1875 in Nasdaq Stock Market trading.
For the full year, the company expects to post about $3.5 million in net income, or about 26 cents a share, compared with a loss of $573,000, or four cents a share, in 1992, Mr. Gury said in an interview.
Sales for the fourth quarter are expected to be about $29.8 million, compared with $22.4 million a year earlier.
For the year, North American Biologicals expects to report about $101.6 million in sales, compared with $82.4 million in 1992.
